Sabra Health Care REIT Q4 2022 Earnings Report
Key Takeaways
Sabra Health Care REIT reported a net loss of $(0.37) per diluted common share for Q4 2022. However, the company's FFO was $0.25, Normalized FFO was $0.37, and AFFO was $0.34. The transition of the 24-property portfolio to Ensign Group and Avamere was completed, and the company made strategic investments and dispositions during the quarter.
Net loss per diluted common share was $(0.37).
FFO was $0.25 per diluted common share.
Normalized FFO was $0.37 per diluted common share.
AFFO was $0.34 per diluted common share.
Sabra Health Care REIT
Sabra Health Care REIT
Sabra Health Care REIT Revenue by Segment
Forward Guidance
Sabra expects 2023 to be relatively quiet as they focus on continued recovery from the pandemic and building investor confidence in their asset classes, with an eye on getting back to earnings growth in 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income